q2 abbott laboratories - Search News

Order byBest matchMost fresh

News

Abbott Laboratories, Q2 and ABT stock

Abbott Laboratories (ABT) Q2 2025 Earnings Call Highlights: Strong Growth in Medical Devices ...

Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds in diagnostics and international markets.

Continue reading

Abbott Laboratories: What's Behind The Q2 Earnings Slump?

Zacks.com on MSN · 1d

Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales Beat

22h

These Analysts Revise Their Forecasts On Abbott Following Q2 Results

Abbott forecasts an adjusted operating margin of approximately 23.5% of sales, down from prior guidance of 23.5%- 24.0%.

1don MSN

Abbott Laboratories falls after setting Q3 outlook below consensus

Shares of Abbott Laboratories (NYSE:ABT) lost ~5% in the premarket on Thursday after the MedTech company provided its ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results